BI 695501 (Cyltezo®; adalimumab-adbm) in rheumatoid arthritis - VJBM

This video discusses the clinical equivalence of BI 695501 (Cyltezo®; adalimumab-adbm) and adalimumab for rheumatoid arthritis - the VOLTAIRE-RA and extension studies.

Cyltezo® Pen (adalimumab-adbm) Autoinjector

Cyltezo (adalimumab): Uses, Side Effects, Dosage & Reviews

Uveitis Cyltezo® (adalimumab-adbm)

Rheumatoid Arthritis Cyltezo® (adalimumab-adbm)

cyltezo

Rheumatoid Arthritis Cyltezo® (adalimumab-adbm)

Evidence for Crohn's Disease

ONKOSHIL . on LinkedIn: #oncology #chemotherapy #oralhealth #oralcare #oralhygiene #oralcancer…

Sam Cavana on LinkedIn: Symposium on Primary Breast Cancer in Older Women

Sam Cavana on LinkedIn: #plainlanguage #omnichannel #publication #ismpp #medcomms #podcast…

Gastroenterology Dosing & Administration

Similar efficacy, safety and immunogenicity of adalimumab biosimilar BI 695501 and Humira reference product in patients with moderately to severely active rheumatoid arthritis: results from the phase III randomised VOLTAIRE- RA equivalence study